Collplant Biotechnologies

Collplant Biotechnologies

Yahoo Finance • 17 hours ago

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

CollPlant Biotechnologies Ltd Proposed new identity reflects the Company's strategic business expansion following its acquisition of LightSolver; change subject to shareholder approval Rehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- C... Full story

Yahoo Finance • last month

CollPlant regains Nasdaq compliance

* CollPlant (CLGN [https://seekingalpha.com/symbol/CLGN]) said [https://seekingalpha.com/pr/20659029-collplant-regains-compliance-with-nasdaq-minimum-bid-price-requirement] on Tuesday it regained compliance with Nasdaq’s $1 minimum bid p... Full story

Yahoo Finance • 2 months ago

COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR

Technological Edge - LightSolver advances the development of the world's first Laser Processing Unit (LPU) – an energy-efficient, pure photonic computing platform Accelerated Growth Path - The transaction positions LightSolver to accelerat... Full story

Yahoo Finance • 2 months ago

COLLPLANT ANNOUNCES REVERSE SHARE SPLIT

REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten reverse share split of the Company's ordina... Full story

Yahoo Finance • 2 months ago

CollPlant to acquire LightSolver, enter photonic computing market

* CollPlant Biotechnologies (CLGN [https://seekingalpha.com/symbol/CLGN]) said [https://seekingalpha.com/pr/20634426-collplant-is-acquiring-lightsolver-enters-supercomputing-and-photonic-computing-markets] on Monday it agreed to acquire... Full story

Yahoo Finance • 5 months ago

Pre-Market Movers: BYAH, LXEO, ELTX Swing Big

(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Prem... Full story

Yahoo Finance • 7 months ago

CollPlant Issues Letter to Shareholders

REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary plant-derived recombinant human collagen (rhCo... Full story

Yahoo Finance • 7 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived rhCollagen for tissue... Full story

Yahoo Finance • 7 months ago

CollPlant receives Nasdaq notice over minimum $1 bid price

* CollPlant Biotechnologies (CLGN [https://seekingalpha.com/symbol/CLGN]) on Tuesday said that it received a written notice from the Nasdaq Stock Market indicating that its ordinary shares have closed below $1.00 for 30 consecutive busin... Full story

Yahoo Finance • last year

CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q2 2025 Earnings Fall Significantly Short of Estimates

CollPlant Biotechnologies Ltd (NASDAQ:CLGN [https://www.chartmill.com/stock/quote/CLGN]) reported second-quarter financial results for 2025 that fell significantly short of analyst expectations, triggering a negative market reaction in pre... Full story

Yahoo Finance • last year

CollPlant Biotechnologies Non-GAAP EPS of -$0.33, revenue of $2.23M misses by $0.31M

* CollPlant Biotechnologies press release [https://seekingalpha.com/pr/20206173-collplant-biotechnologies-reports-2025-second-quarter-financial-results-and-provides] (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]): Q2 Non-GAAP EPS o... Full story

Yahoo Finance • last year

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

REHOVOT, Israel, Aug. 5, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue r... Full story

Yahoo Finance • last year

CollPlant files to sell 1.27M ordinary shares for holders

* CollPlant (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]) filed to sell 1.27M ordinary shares for holders. * Filing [https://seekingalpha.com/filing/10106901] MORE ON COLLPLANT BIOTECHNOLOGIES * CollPlant shares rise on expa... Full story

Yahoo Finance • last year

CollPlant Biotechnologies shares slide after announces capital raise $3.6M through registered direct offering

CollPlant Biotechnologies (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]) said Friday that it will undertake a registered direct offering and concurrent private placement [https://seekingalpha.com/pr/20121085-collplant-biotechnologies... Full story

Yahoo Finance • 4 years ago

Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman

Former Worldwide Head of Licensing and Acquisition and Knowledge Management at Merck & Co., where he led the completion of more than150 business development transactions Former Global Head of Infectious Diseases for Johnson & Johnson Pharm... Full story